Methods of obtaining antibody directed against prothrombin fragments F2/F1+2

US6538113B1 · kind B1 · utility

Assignee

• Dade Behring Marburg GmbH · DE

Inventors

• Hermann Pelzer · Cölbe, DE
• Werner Stuber · Lahntal, DE

Key dates

• Filing date: Jun 7, 1995
• Grant date: Mar 25, 2003
• Expiry date: Jun 7, 2015

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y10S530/806
• WIPO field: Measurement
• WIPO sector: Instruments

Abstract

The invention relates to synthetic peptides which have amino acid sequences which correspond, in whole or in part, to the amino acid sequence of prothrombin and are antigenic, to the use thereof for the immunization of an animal and for the purification of specific antibodies, to antibodies against these peptides, and to the use of the antibodies for the determination of the fragments F2/F1+2. The antibodies hitherto used for the determination of the content of the fragments F2/F1+2 have been induced by immunization with natural, highly purified prothrombin fragments F2/F1+2. The isolation of these prothrombin fragments is elaborate and costly, and the antibodies generated therewith show cross-reactions with intact prothrombin. Used for the immunization according to the invention are synthetic peptides which have amino acid sequences which correspond, in whole or in part, to the amino acid sequence of prothrombin and are antigenic. The resulting antibodies react specifically with the antigen used for the immunization; if the peptides contain the carboxyl-terminal amino acid sequence of the fragments F2/F1+2 resulting after cleavage of the prothrombin molecule with factor Xa, then t…